These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11064305)

  • 1. Chapter 2. Guidelines and recommendations for ICD therapy.
    Noorani HZ
    Can J Cardiol; 2000 Oct; 16(10):1303-6. PubMed ID: 11064305
    [No Abstract]   [Full Text] [Related]  

  • 2. Chapter 1. Summary of the CCS Consensus Conference on prevention of sudden death from cardiac arrhythmia.
    Connolly SJ; Talajic M
    Can J Cardiol; 2000 Oct; 16(10):1298-302. PubMed ID: 11064304
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 4. [Regarding the French Society of Cardiologists' guidelines on the indications for implantable automatic ventricular defibrillators].
    Daubert JC
    Arch Mal Coeur Vaiss; 2006 Feb; 99(2):93-4. PubMed ID: 16555690
    [No Abstract]   [Full Text] [Related]  

  • 5. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.
    Hauer RN; Aliot E; Block M; Capucci A; Lüderitz B; Santini M; Vardas PE;
    Eur Heart J; 2001 Jul; 22(13):1074-81. PubMed ID: 11428848
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantable cardioverter defibrillator (ICD) in children.
    Eicken A; Kolb C; Lange S; Brodherr-Heberlein S; Zrenner B; Schreiber C; Hess J
    Int J Cardiol; 2006 Feb; 107(1):30-5. PubMed ID: 16337494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Defibrillators--end of sudden cardiac death?].
    Kozák M
    Vnitr Lek; 2004 Oct; 50 Suppl 1():S63-7. PubMed ID: 15651143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Implantable cardioverter-defibrillators in the prevention of sudden cardiac death].
    Kozák M; Krivan L; Semrád B
    Vnitr Lek; 2001 Jun; 47(6):361-70. PubMed ID: 11494881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prophylactic ICD? Who are the patients? What is the device?
    Nisam S
    Europace; 2001 Oct; 3(4):269-74. PubMed ID: 11678383
    [No Abstract]   [Full Text] [Related]  

  • 11. Present guidelines for device implantation: clinical considerations and clinical challenges from pacing, implantable cardiac defibrillator, and cardiac resynchronization therapy.
    Poole JE
    Circulation; 2014 Jan; 129(3):383-94. PubMed ID: 24446408
    [No Abstract]   [Full Text] [Related]  

  • 12. Implantable defibrillator therapy.
    Alings AM
    Neth J Med; 2003 May; 61(5 Suppl):4-7. PubMed ID: 12918543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications for the implantable cardiac defibrillator].
    Ben Ameur Y; Baraket F; Terras M; Longo S; Kraiem S; Hmem M; Slimane ML
    Tunis Med; 2003; 81 Suppl 8():601-12. PubMed ID: 14608747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable defibrillators and sudden cardiac death.
    Josephson M; Wellens HJ
    Circulation; 2004 Jun; 109(22):2685-91. PubMed ID: 15184292
    [No Abstract]   [Full Text] [Related]  

  • 15. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the "emergency room in the chest".
    Campbell S
    Health Care Strateg Manage; 1998 Mar; 16(3):17. PubMed ID: 10177104
    [No Abstract]   [Full Text] [Related]  

  • 17. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment with cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Gosling OE; Bellenger N; Spurrell P
    Heart; 2009 Nov; 95(22):1843. PubMed ID: 19875370
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sudden cardiac death, ICD and resynchronization therapy].
    Schaumann A; Tack C; Kuck KH
    Herz; 2006 Dec; 31(9):857-63. PubMed ID: 17180648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New aspects of ICD therapy: from rhythm therapy to complex cardiac monitoring. Development of an implantable, ICD-assisted, intrathoracic 6-channel ECG for continuous monitoring of high infarct risk patients].
    Grom A; Zehender M
    Biomed Tech (Berl); 2002 Oct; 47(9-10):234-8. PubMed ID: 12369210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.